Galapagos | GLPG - Current Assets

Stock Price
28.74
Daily Change
-0.16 -0.55%
Monthly
5.27%
Yearly
30.52%
Q1 Forecast
27.75

Galapagos reported EUR3.16B in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
argenx SE USD 5.83B 946.64M Jun/2025
AstraZeneca USD 29.94B 1B Sep/2025
Biogen USD 8.94B 968.9M Sep/2025
Genmab DKK 3.91B 127M Jun/2025
Gilead Sciences USD 18.84B 4.12B Sep/2025
GlaxoSmithKline GBP 17.84B 169M Sep/2025
GRIFOLS EUR 5.35B 102.57M Sep/2025
Hikma Pharmaceutical USD 2.56B 294M Jun/2025
Incyte USD 4.28B 634.19M Sep/2025
Merck EUR 12.88B 680M Sep/2025
Neurocrine Biosciences USD 2.16B 409.5M Sep/2025
Novartis USD 28.2B 2.26B Sep/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Sanofi EUR 30.95B 3.09B Dec/2025
UCB EUR 4.79B 1.47B Dec/2024
Vertex Pharmaceuticals USD 10.57B 141.7M Sep/2025